Related Experiment Video
Updated: Jul 22, 2025

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
Published on: December 26, 2015
Functional micro-RNA drugs acting as a fate manipulator in the regulation of osteoblastic death
Zhengwen Cai1,2, Fengshuo Liu1, Yong Li1,2
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China. sirongshi@scu.edu.cn.
Abstract:
Bone loss is prevalent in clinical pathological phenomena such as osteoporosis, which is characterized by decreased osteoblast function and number, increased osteoclast activity, and imbalanced bone homeostasis. However, current treatment strategies for bone diseases are limited. Regulated cell death (RCD) is a programmed cell death pattern activated by the expression of specific genes in response to environmental changes. Various studies have shown that RCD is closely associated with bone diseases, and manipulating the death fate of osteoblasts could contribute to effective bone treatment. Recently, microRNA-targeting therapy drugs have emerged as a potential solution because of their precise targeting, powerful curative effect, and limited side effects. Nevertheless, their clinical application is limited by their inherent instability, easy enzymatic degradation, and poor membrane penetrability. To address this challenge, a self-assembling tetrahedral DNA nanostructure (TDN)-based microRNA (Tmi) delivery system has been proposed. TDN features excellent biocompatibility, cell membrane penetrability, serum stability, and modification versatility, making it an ideal nucleic acid carrier for miRNA protection and intracellular transport. Once inside cells, Tmi can dissociate and release miRNAs to manipulate key molecules in the RCD signaling pathway, thereby regulating bone homeostasis and curing diseases caused by abnormal RCD activation. In this paper, we discuss the impact of the miRNA network on the initiation and termination of four critical RCD programs in bone tissues: apoptosis, autophagy, pyroptosis, and ferroptosis. Furthermore, we present the Tmi delivery system as a miRNA drug vector. This provides insight into the clinical translation of miRNA nucleic acid drugs and the application of miRNA drugs in bone diseases.
Insights
Regulated cell death (RCD) influences bone diseases like osteoporosis. A novel tetrahedral DNA nanostructure (TDN) delivers microRNAs (miRNAs) to target RCD pathways, offering a promising therapeutic strategy for bone loss.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Nanotechnology
Background:
- Bone loss, exemplified by osteoporosis, involves impaired osteoblast function, increased osteoclast activity, and disrupted bone homeostasis.
- Current treatments for bone diseases are limited, highlighting the need for innovative therapeutic approaches.
- Regulated cell death (RCD) pathways are implicated in bone diseases, suggesting that modulating osteoblast fate could be a viable treatment strategy.
Purpose of the Study:
- To explore the role of microRNA (miRNA) networks in regulating key RCD programs (apoptosis, autophagy, pyroptosis, ferroptosis) within bone tissues.
- To introduce a novel self-assembling tetrahedral DNA nanostructure (TDN)-based microRNA (Tmi) delivery system for enhanced miRNA therapy.
- To provide insights into the clinical translation of miRNA-based therapies for bone diseases.
Main Methods:
- Investigated the impact of the miRNA network on four critical RCD programs in bone.
- Developed and characterized a tetrahedral DNA nanostructure (TDN) for microRNA (miRNA) delivery (Tmi system).
- Evaluated the potential of the Tmi system for protecting miRNAs and facilitating intracellular transport to regulate RCD pathways.
Main Results:
- miRNA networks significantly influence the initiation and progression of apoptosis, autophagy, pyroptosis, and ferroptosis in bone.
- The TDN-based Tmi system demonstrates excellent biocompatibility, cell penetration, and stability for miRNA delivery.
- The Tmi system effectively releases miRNAs intracellularly to modulate RCD signaling pathways.
Conclusions:
- miRNA targeting via the Tmi delivery system offers a promising strategy for treating bone diseases characterized by abnormal RCD.
- The TDN platform provides a versatile and effective vector for miRNA nucleic acid drugs, overcoming limitations of current delivery methods.
- This approach holds potential for advancing the clinical application of miRNA therapeutics in bone regenerative medicine and disease treatment.
Related Concept Videos
MicroRNAs
Drugs that Destabilize Microtubules
Osteoclasts in Bone Remodeling
Regulation of Expression at Multiple Steps
Bone Remodeling

